SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

TuHURA reports partial tumor remissions in first three patients

TuHURA reported partial tumor remissions in the first three patients in a study of IFx-2.0 with Keytruda.

HURA

Related stories